Healx News

This is selected news for Healx, which is filed under Sectors / Healthtech. There are 133 news items for this page. Healx is occasionally combined with Tim Guilliams, Jonathan Milner and btov Partners in news items.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/19/2022 Autosomal Dominant Polycystic Kidney Disease Market to Surge at a Significant CAGR of 14.5% by 2032 | DelveInsight
... analysis, the total ADPKD diagnosed prevalent cases in the 7MM were approximately 367K in 2021. Leading ADPKD companies such as Galapagos NV, Reata Pharmaceuticals, Kadmon Pharmaceuticals, Sanofi, Anakuria Therapeutics, Regulus Therapeutics, AceLink Therapeutics, Healx, XORTX Therapeutics, Poxel, Alebund Pharmaceuticals, Chinook Therapeutics, and others are developing novel ADPKD drugs that can ...
PR Newswire
9/13/2022 Reviewing Ovid Therapeutics (NASDAQ:OVID) and BriaCell Therapeutics (NASDAQ:BCTX)
... a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The ...
Daily Political
8/13/2022 Andrew Watson, Vice President of AI and R & D at Healx - Interview Series - New York Tech Media
Andrew Watson is Vice President of AI and R & D at Healx. Prior to joining Healx he worked at the technology giant Dyson, where he was the founding member of the Machine Learning Research Department, leading the research and implementation of machine learning and artificial intelligence across a variety of ...
8/9/2022 England's Rare Diseases Action Plan Needs AI To Succeed
Dr. Tim Guilliams, co-founder and CEO of Healx , is an advocate for harnessing the power of AI to accelerate treatments for rare diseases. Rare diseases are largely overlooked by pharmaceutical companies and traditional drug discovery methods, despite the fact that 1 in 17 people in the UK will be ...
6/6/2022 Global Drug Discovery Software Market valued at $2 billion in 2020, is poised to grow at a decent CAGR of 14% to reach $3.5 billion by 2025
... CROs. Competitive Landscape Analysis: Drug Discovery Software Market The global drug discovery software market is highly competitive and fragmented. Some of the top market players include Dassault Systèmes, LabVantage, PerkinElmer, Schrodinger, Abbott, Healx, Optibrium, Instem, Chemical Computing Group, dotmatics, idbs, Titian, Biovia, Celsius, Genome Biologics, Atomwise, Standigm, insitro, and ...
3/21/2022 Healx Co-Founder and CEO Tim Guilliams will speak at the EU-Startups Summit in Barcelona on May 12-13! eu-startups.com
3/11/2022 Founder in Five: Q&A with Healx CEO Tim Guilliams uktech.news
3/2/2022 How Healx uses AI to transform rare disease drug discovery [PODCAST] clarivate.com
2/25/2022 Gaboxadol in Combo Therapy for Fragile X Worth Pursuing: Healx fragilexnewstoday.com
2/8/2022 Healx and Ovid Enter Strategic Partnership on Fragile X Syndrome Therapy globalgenes.org
2/8/2022 Ovid pens deal to offload twice-failed former lead program, positioning Healx to write new chapter in fragile X FierceBiotech
2/8/2022 Healx and Ovid Therapeutics to Enter Strategic Partnership Globe Newswire
2/8/2022 Healx and Ovid Therapeutics Partner on Fragile X Therapy pharmalive.com
2/8/2022 Healx and Ovid Therapeutics to Enter Strategic Partnership | Insider Tracking insidertracking.com
2/8/2022 Ovid and Healx Enter Partnership to Develop Fragile X Treatment Inside Precision Medicine
2/8/2022 Ovid Therapeutics & Healx to Enter Strategic Partnership drug-dev.com
2/8/2022 Healx and Ovid Therapeutics to Enter Strategic Partnership forextv.com
10/20/2021 UK startup Healx to begin clinical trial on repositioned drug for Fragile X syndrome TechCrunch
10/20/2021 Clinical Trials Expand For AI-Designed Drug To Treat Fragile X Syndrome Forbes
8/10/2021 Healx Enters Partnership with Ono Pharmaceutical to Repurpose Drugs for Rare Diseases globalgenes.org
8/5/2021 Healx partners with Ono Pharmaceutical to expand AI capabilities for rare diseases epmmagazine.com
4/9/2021 Healx launches partnership with Ataxia UK and FARA to find treatments for rare neurodegenerative condition FirstWord PHARMA
4/8/2021 Healx partners with Ataxia UK and FARA to find treatments for Friedreich's ataxia drugdiscoverytoday.com
1/13/2021 Healx teams up with Mission: Cure to discover and advance the world's first treatments for chronic pancreatitis drugdiscoverytoday.com
8/25/2020 Global Rare Neurological Disease Treatment Market (2020 to 2027) - Analysis and Forecasts PR Newswire